Advertisement

Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.

Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.

The Danish pharmaceutical firm, Europe’s most valuable company, said sales of the weight-loss drug jumped 106% in the first quarter.